Advertisement

Topics

AnagnosTec Gesellschaft für Company Profile

11:30 EDT 22nd September 2017 | BioPortfolio

AnagnosTec was founded in 1998 as a spin-off from the University of Technology, Berlin. The company offers services, contract research and products for bioanalytical applications based on MALDI-TOF Mass Spectrometry.The research at AnagnosTec is mainly focused on the development of novel mass spectrometric techniques in the fields of biotechnology, clinical medicine, microbiology, food industry and on the development of intelligent software solutions to handle and interpret mass spectrometric data.AnagnosTec's staff currently consists of 10 employees. Among our latest products are a new rapid technique for the direct analysis of secondary metabolites from unfractionated cells or tissue probes, as well as the determination of molecular masses and structure elucidation using Post Source Decay (PSD). Other recent applications include the rapid characterisation and classification of whole microorganisms by Intact-Cell-MALDI-TOF Mass Spectrometry. Anagnostec's SARAMIS system analyses MALDI-TOF fingerprint mass spectra to identify the microorganism with the best database match. The dendrogram feature classifies unknown isolates into a taxonomic tree and dereplicates duplicate strains simultaneously to improve drug discovery processes. Large microbial strain collections can be screened in high-troughput by using an in-house-built biohandling robot designed to pick microbial colonies from agar plates and to transfer the biomass to the MALDI target plate.

Location

Analytische Biochemie & Diagnostik mbHIm Biotechnologiepark, TGZ II

Luckenwalde
Luckenwalde
14943
Germany

Contact

Phone: 49 3371 68 11 26
Fax: 49 3371 68 11 27
Email: anagnostec@anagnostec.de


News Articles [40 Associated News Articles listed on BioPortfolio]

Anthrax: A hidden threat to wildlife in the tropics

(Max-Planck-Gesellschaft) Researchers illuminate the epidemiology of a cryptic pathogen.

Tracking the mechanisms of artery formation

(Max-Planck-Gesellschaft) The Notch signal pathway could be the basis for new therapies for cardiovascular diseases.

Epigenetics between the generations

(Max-Planck-Gesellschaft) Max Planck researchers prove that we inherit more than just genes.

BB Biotech: Gesundheitsdebatte in den USA bringt Unsicherheiten

BB Biotech hat am Freitag Quartalszahlen vorgelegt. Die Gesellschaft, die sich auf Beteiligungen im Biotechsektor spezialisiert hat, meldet einen Anstieg des inneren Wertes auf Schweizer-Franken-Ba...

Mutation speeds up sperm of zebra finches

(Max-Planck-Gesellschaft) Gene inversion gives reproductive advantage to zebra finches.

Mologen: Versicherer steigt groß ein - wie reagiert die Aktie?

Liebe Leser, wie kürzlich bekannt wurde, hat die Signal Krankenversicherung einen nicht unwesentlichen Teil am Stammkapital der Gesellschaft Mologen erworben. Wie aus einer Stimmrechtsmeldung hervo.....

Epigenomics muss Prognose für 2017 reduzieren

In den USA entwickeln sich die Geschäfte von Epigenomics mit dem neu zugelassenen Darmkrebstest Epi proColon langsamer als erwartet. Als Folge daraus reduziert die Gesellschaft ihre Prognose für da....

Evotec nach dem Rücksetzer - auf diese Marken müssen Sie jetzt achten!

Das Hamburger Biotech-Unternehmen Evotec hat in der vergangenen Woche seine Zusammenarbeit mit dem renommierten Fraunhofer-Institut ausgebaut. Wie die Gesellschaft bekannt gab, erstreckt sich die K...

Drugs and Medications [0 Results]

None

Clinical Trials [4 Associated Clinical Trials listed on BioPortfolio]

A Study of the Current Medical Practice and Outcomes in the Treatment of Type 2 Diabetes Mellitus in an Office Setting (MK-0431-199)

The purpose of this study is to collect information of the risk profile of patients with type 2 diabetes mellitus, their treatment concerning meeting the guidelines for treatment of diabet...

Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)

The OMS/DES study is a multinational European Trial for Children with the Opsoclonus Myoclonus Syndrome / Dancing Eye Syndrome. This trial brought on the way by specialists of the EPNS (E...

Ziprasidone for Severe Conduct and Other Disruptive Behavior Disorders

To investigate and compare the efficacy, safety and tolerability of ziprasidone versus placebo in the treatment of conduct disorder (CD), oppositional defiant disorder (ODD) and disruptive...

Effects of Empagliflozin Plus Linagliptin vs Metformin Plus Insulin Glargin on Renal and Vascular Changes in Type 2 Diabetes

Diabetes mellitus is a wide-spread disease accompanied by strongly increased morbidity and mortality due to micro- and macrovascular complications. However, in studies with patients suffer...

Companies [17 Associated Companies listed on BioPortfolio]

AnagnosTec Gesellschaft für

AnagnosTec was founded in 1998 as a spin-off from the University of Technology, Berlin. The company offers services, contract research and products for bioanalytical applications based on MALDI-TOF Ma...

ICHTHYOL-GESELLSCHAFT

ICHTHYOL-GESELLSCHAFT, our independent, family-run pharmaceutical company became one of the most important suppliers of therapeutics in dermatology and orthopedics due to active ingredients of high gr...

Gesellschaft für Toxikologie (GT)

NIL

Gesellschaft Deutscher Chemiker

Nil

Fraunhofer-Gesellschaft

The Fraunhofer-Gesellschaft undertakes applied research of direct utility to private and public enterprise and of wide benefit to society. Its services are solicited by customers and contractual partn...

More Information about "AnagnosTec Gesellschaft für" on BioPortfolio

We have published hundreds of AnagnosTec Gesellschaft für news stories on BioPortfolio along with dozens of AnagnosTec Gesellschaft für Clinical Trials and PubMed Articles about AnagnosTec Gesellschaft für for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of AnagnosTec Gesellschaft für Companies in our database. You can also find out about relevant AnagnosTec Gesellschaft für Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Food
Food is any substance consumed to provide nutritional support for the body. It is usually of plant or animal origin, and contains essential nutrients, such as carbohydrates, fats, proteins, vitamins, or minerals. The substance is ingested by an organism ...


Corporate Database Quicklinks



Searches Linking to this Company Record